Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
SwedenStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
SwedenStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
SwedenStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SwedenSacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
SwedenOrlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity
SwedenPhase II Study of ME-401, Rituximab and Bendamustine as First‑Line Treatment for High‑Risk and Low‑Risk Follicular Lymphoma Patients
SwedenEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
SwedenEvaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies
SwedenEP395 and drug combination (verapamil, midazolam, digoxin) pharmacokinetic study in healthy volunteers with COPD
SwedenPhase 1 randomized, placebo-controlled study of ROSE-010 and paracetamol on appetite in overweight and obese adults
SwedenA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
